uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Enterprise Value (2015 - 2026)

uniQure (QURE) posted quarterly Enterprise Value of -$810.3 million for Q2 2026, down 114.96% year-over-year from $5.4 billion in Q2 2025, and down 38.15% quarter-over-quarter from -$586.6 million in Q1 2026.

Analysis

uniQure (QURE) Enterprise Value (2015 - 2026) Analysis & Trends

uniQure's Enterprise Value history runs 12 years deep, the most recent figure standing at -$810.3 million for Q2 2026.

  • In Q2 2026, Enterprise Value fell 114.96% year-over-year to -$810.3 million; the TTM figure through Jun 2026 stood at -$810.3 million (down 114.96% YoY), while the FY2025 annual figure was -$622.5 million, down 69.39% from the prior year.
  • Enterprise Value for Q2 2026 stood at -$810.3 million, down from -$586.6 million in the prior quarter.
  • The five-year high for Enterprise Value was -$315.3 million in Q1 2023, with the low at -$810.3 million in Q2 2026.
  • The 5-year median for Enterprise Value is -$524.7 million (2022), against an average of -$523.4 million.
  • The sharpest annual moves came in 2024 and 2026: Enterprise Value surged 40.52% in 2024, then sank 114.96% in 2026.
  • uniQure's Enterprise Value stood at -$352.8 million in 2022, then slumped by 75.12% to -$617.9 million in 2023, then soared by 40.52% to -$367.5 million in 2024, then tumbled by 69.39% to -$622.5 million in 2025, then slumped by 30.17% to -$810.3 million in 2026.
  • Business Quant data shows QURE's Enterprise Value at -$810.3 million in Q2 2026, -$586.6 million in Q1 2026, and -$622.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.38 Bn
Mar 31, 2026 444.04 Mn
Dec 31, 2025 869.18 Mn
Sep 30, 2025 2.93 Bn
Jun 30, 2025 387.85 Mn
Mar 31, 2025 170.79 Mn
Dec 31, 2024 497.61 Mn
Sep 30, 2024 -194.96 Mn
Jun 30, 2024 -306.28 Mn
Mar 31, 2024 -303.52 Mn
Dec 31, 2023 -294.06 Mn
Sep 30, 2023 -338.10 Mn
Jun 30, 2023 -81.90 Mn
Mar 31, 2023 642.25 Mn
Dec 31, 2022 711.92 Mn
Sep 30, 2022 437.94 Mn
Jun 30, 2022 369.68 Mn
Mar 31, 2022 317.92 Mn
Dec 31, 2021 403.98 Mn
Sep 30, 2021 900.65 Mn